{
  "experiment_info": {
    "experiment_name": "paper_18_3D_Multi-Cell",
    "run_number": 9,
    "total_runs": 10,
    "timestamp": "20250624_020624",
    "run_start_time": "2025-06-24T03:54:06.646123",
    "run_end_time": "2025-06-24T03:54:56.276088"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T03:54:06.647117",
      "data": {
        "description": "We present a 3D multi-cell simulation of a generic simplification of vascular tumor growth which can be easily extended and adapted to describe more specific vascular tumor types and host tissues. Initially, tumor cells proliferate as they take up the oxygen which the pre-existing vasculature supplies. The tumor grows exponentially. When the oxygen level drops below a threshold, the tumor cells become hypoxic and start secreting pro-angiogenic factors. At this stage, the tumor reaches a maximum diameter characteristic of an avascular tumor spheroid. The endothelial cells in the pre-existing vasculature respond to the pro-angiogenic factors both by chemotaxing towards higher concentrations of pro-angiogenic factors and by forming new blood vessels via angiogenesis. The tumor-induced vasculature increases the growth rate of the resulting vascularized solid tumor compared to an avascular tumor, allowing the tumor to grow beyond the spheroid in these lineargrowth phases. First, in the linear-spherical phase of growth, the tumor remains spherical while its volume increases. Second, in the linear-cylindrical phase of growth the tumor elongates into a cylinder. Finally, in the linear-sheet phase of growth, tumor growth accelerates as the tumor changes from cylindrical to paddle-shaped. Substantial periods during which the tumor grows slowly or not at all separate the exponential from the linear-spherical and the linear-spherical from the linear-cylindrical growth phases. In contrast to other simulations in which avascular tumors remain spherical, our simulated avascular tumors form cylinders following the blood vessels, leading to a different distribution of hypoxic cells within the tumor. Our simulations cover time periods which are long enough to produce a range of biologically reasonable complex morphologies, allowing us to study how tumor-induced angiogenesis affects the growth rate, size and morphology of simulated tumors."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:54:34.083221",
      "prompt": "Original description: We present a 3D multi-cell simulation of a generic simplification of vascular tumor growth which can be easily extended and adapted to describe more specific vascular tumor types and host tissues. Initially, tumor cells proliferate as they take up the oxygen which the pre-existing vasculature supplies. The tumor grows exponentially. When the oxygen level drops below a threshold, the tumor cells become hypoxic and start secreting pro-angiogenic factors. At this stage, the tumor reaches a maximum diameter characteristic of an avascular tumor spheroid. The endothelial cells in the pre-existing vasculature respond to the pro-angiogenic factors both by chemotaxing towards higher concentrations of pro-angiogenic factors and by forming new blood vessels via angiogenesis. The tumor-induced vasculature increases the growth rate of the resulting vascularized solid tumor compared to an avascular tumor, allowing the tumor to grow beyond the spheroid in these lineargrowth phases. First, in the linear-spherical phase of growth, the tumor remains spherical while its volume increases. Second, in the linear-cylindrical phase of growth the tumor elongates into a cylinder. Finally, in the linear-sheet phase of growth, tumor growth accelerates as the tumor changes from cylindrical to paddle-shaped. Substantial periods during which the tumor grows slowly or not at all separate the exponential from the linear-spherical and the linear-spherical from the linear-cylindrical growth phases. In contrast to other simulations in which avascular tumors remain spherical, our simulated avascular tumors form cylinders following the blood vessels, leading to a different distribution of hypoxic cells within the tumor. Our simulations cover time periods which are long enough to produce a range of biologically reasonable complex morphologies, allowing us to study how tumor-induced angiogenesis affects the growth rate, size and morphology of simulated tumors.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, let's tackle this problem. The user wants me to create a JSON object with ontology annotations based on the provided biological simulation description. The categories must be CellOntology, GeneOntology, and MeSH, each with their respective IDs and terms.\n\nFirst, I'll parse the original description to identify relevant terms. The text mentions tumor cells, endothelial cells, hypoxic conditions, angiogenesis, cell proliferation, chemotaxis, and vascular development. \n\nFor CellOntology, tumor cells are likely CL:0008001 (neoplastic cell), and endothelial cells are CL:0000115. Hypoxic cells might not have a specific CL term, but since hypoxia is a condition, maybe it's better to focus on the cell types involved. Wait, the text says \"tumor cells become hypoxic\"\u2014so hypoxic cells aren't a separate cell type but a state. Maybe the CL terms should be the cell types mentioned: neoplastic cells and endothelial cells.\n\nNext, GeneOntology terms. Processes mentioned include cell proliferation (GO:0008283), angiogenesis (GO:0001525), response to hypoxia (GO:0001666), chemotaxis (GO:0006935), and blood vessel development (GO:0001568). I need to check the exact terms. For example, \"secreting pro-angiogenic factors\" might fall under 'angiogenesis' or 'positive regulation of angiogenesis'. The description says endothelial cells respond by chemotaxing towards higher concentrations, so chemotaxis (GO:0006935) is correct. Blood vessel formation via angiogenesis is part of blood vessel development (GO:0001568).\n\nFor MeSH terms, the main topics are Neoplasm Angiogenesis (D018345), Hypoxia (D000860), Cell Proliferation (D049109), Chemotaxis (D002648), and Neovascularization, Pathologic (D018352). Neoplasm Angiogenesis is specific to tumors, and Pathologic Neovascularization might also apply here. Hypoxia is straightforward. Cell Proliferation is a key term mentioned in the exponential growth phase.\n\nNow, I need to ensure IDs are correctly formatted without spaces. For example, MeSH terms like D018345 for angiogenesis. Also, term names must be exact. \"Chemotaxis\" is correct, not \"Cell Chemotaxis\". \n\nWait, the example uses \"Cell Division\" as a GO term. So in the original text, when they talk about tumor cells proliferating, the GO term should be \"cell proliferation\" (GO:0008283). Hypoxic response is GO:0001666. Angiogenesis is GO:0001525. Endothelial cells forming blood vessels via angiogenesis might also relate to 'blood vessel morphogenesis' (GO:0048514), but the description specifically mentions angiogenesis, so GO:0001525 is correct. \n\nDouble-checking the MeSH terms: Pathologic neovascularization is D018352, which is different from normal angiogenesis. Since the context is tumor-induced, D018352 is appropriate. Neoplasm Angiogenesis is D018345. Both might be relevant, but the description mentions tumor-induced vasculature, so including both might be necessary. However, the user might prefer the most specific terms. Let's check MeSH terms. \"Angiogenesis\" in tumors is D018345 (Neovascularization, Pathologic), which is under D018352. Wait, D018345 is the ID for Neoplasm Angiogenesis. Let me confirm: MeSH term for angiogenesis in neoplasms is D018345. Yes. So including that. Also, Hypoxia is D000860. Cell Proliferation is D049109. Chemotaxis is D002648.\n\nPutting it all together:\n\nCellOntology should have neoplastic cells (CL:0008001) and endothelial cells (CL:0000115).\n\nGeneOntology includes cell proliferation (GO:0008283), angiogenesis (GO:0001525), response to hypoxia (GO:0001666), chemotaxis (GO:0006935), and blood vessel development (GO:0001568).\n\nMeSH terms are Neoplasm Angiogenesis (D018345), Hypoxia (D000860), Cell Proliferation (D049109), Chemotaxis (D002648), and Neovascularization, Pathologic (D018352). Wait, maybe the last one is redundant? Since D018345 is a child of D018352. But the description mentions both the process in the tumor and the pathologic aspect. To cover both, maybe include both. But the user might prefer conciseness. Alternatively, check if the term \"Neovascularization, Pathologic\" (D018352) is the broader term, and \"Angiogenesis\" in this context is part of that. Hmm. The original text refers to \"tumor-induced angiogenesis\" which is pathologic, so D018352 is appropriate. But D018345 is also relevant. To avoid redundancy, perhaps include D018352 and D018345? Or choose the most specific. The example included multiple terms if applicable. So including both might be okay.\n\nWait, the example only has one term per category, but the user's request allows multiple. So I can include all relevant terms.\n\nNow, check exact term names. For example, MeSH term for Hypoxia is \"Hypoxia\" (D000860), which matches. \"Cell Proliferation\" is D049109. \"Chemotaxis\" is D002648. \"Neoplasm Angiogenesis\" is D018345. \"Neovascularization, Pathologic\" is D018352.\n\nSo the final JSON should have these entries, making sure all IDs and terms are correctly formatted without extra spaces. Also, category names must be exact: CellOntology, GeneOntology, MeSH.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0008001\",\n            \"term\": \"neoplastic cell\"\n        },\n        {\n            \"id\": \"CL:0000115\",\n            \"term\": \"endothelial cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0008283\",\n            \"term\": \"cell proliferation\"\n        },\n        {\n            \"id\": \"GO:0001525\",\n            \"term\": \"angiogenesis\"\n        },\n        {\n            \"id\": \"GO:0001666\",\n            \"term\": \"response to hypoxia\"\n        },\n        {\n            \"id\": \"GO:0006935\",\n            \"term\": \"chemotaxis\"\n        },\n        {\n            \"id\": \"GO:0001568\",\n            \"term\": \"blood vessel development\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D018345\",\n            \"term\": \"Neoplasm Angiogenesis\"\n        },\n        {\n            \"id\": \"D000860\",\n            \"term\": \"Hypoxia\"\n        },\n        {\n            \"id\": \"D049109\",\n            \"term\": \"Cell Proliferation\"\n        },\n        {\n            \"id\": \"D002648\",\n            \"term\": \"Chemotaxis\"\n        },\n        {\n            \"id\": \"D018352\",\n            \"term\": \"Neovascularization, Pathologic\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:54:56.222959",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'endothelial cell (CL:0000115)', 'neoplastic cell (CL:0008001)'}, 'GeneOntology': {'response to hypoxia (GO:0001666)', 'chemotaxis (GO:0006935)', 'blood vessel development (GO:0001568)', 'cell proliferation (GO:0008283)', 'angiogenesis (GO:0001525)'}, 'MeSH': {'Neoplasm Angiogenesis (D018345)', 'Hypoxia (D000860)', 'Cell Proliferation (D049109)', 'Neovascularization, Pathologic (D018352)', 'Chemotaxis (D002648)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D Python script.\n\nFirst, the necessary imports: CompuCellSetup and the steppables module. Then, a simulation class that inherits from SteppableBasePy. The class must have __init__, start, and step methods.\n\nThe ontology annotations mention two cell types: endothelial and neoplastic cells. So I'll define those in the start method using self.cellType. The GeneOntology terms include response to hypoxia, chemotaxis, blood vessel development, cell proliferation, and angiogenesis. MeSH terms relate to neoplasm angiogenesis, hypoxia, cell proliferation, pathologic neovascularization, and chemotaxis.\n\nI should incorporate parameters that reflect these processes. For hypoxia response, maybe set a hypoxia threshold and a VEGF secretion rate. Chemotaxis can be handled by adding a chemical field (like VEGF) and setting up chemotaxis parameters for endothelial cells towards VEGF. Cell proliferation can be controlled by a probability parameter, adjusting the growth rate.\n\nIn the __init__ method, I'll initialize the basic simulation parameters. The start method will define cell types and set up the initial cells. Maybe place some neoplastic cells and endothelial cells initially. Also, set up the VEGF field and configure chemotaxis here.\n\nIn the step method, during each Monte Carlo Step (MCS), I'll check conditions for hypoxia. If a cell is neoplastic and the local VEGF concentration is above the threshold, maybe increase proliferation probability. For endothelial cells, maybe check if they should undergo chemotaxis or angiogenesis. Also, handle cell division based on the proliferation probability.\n\nI need to make sure to register the steppable with CompuCellSetup at the end. Also, include the standard run line. Remember to use the right syntax for adding steppables and initializing the simulation.\n\nWait, for the VEGF field, I should declare it as a ChemicalField in the simulation. Then in the start method, set up chemotaxis by using the FlexibleDiffusionSolverFE and adding the chemical field to it. Also, configure the diffusion parameters and decay rate if needed.\n\nFor cell division, maybe use the divideCell function. But in the step method, loop through all cells and apply the proliferation probability. When a cell is to divide, split it. Also, for hypoxia response, maybe have neoplastic cells secrete VEGF when they're under hypoxic conditions.\n\nI think that's the basic structure. Let me put it all together, making sure all required methods are present and parameters are based on the ontology terms provided.\n</think>\n\n```python\nfrom pyevtk.hl import *\nfrom math import *\nimport random\nimport CompuCellSetup\nfrom CompuCellSetup import sim\nimport sys\nfrom PySteppables import *\n\nclass AngiogenesisSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        SteppableBasePy.__init__(self, _simulator, _frequency)\n        self.hypoxia_threshold = 0.2\n        self.proliferation_prob = 0.01\n        self.vegf_secretion_rate = 0.1\n        self.chemotaxis_strength = 10.0\n\n    def start(self):\n        self.cell_type_endothelial = self.cellType(\"ENDOTHELIAL\")\n        self.cell_type_neoplastic = self.cellType(\"NEOPLASTIC\")\n        \n        self.vessel_field = self.createChemotaxisField('VEGF')\n        self.addChemotaxisData(self.cell_type_endothelial, 'VEGF', self.chemotaxis_strength)\n        \n        for cell in self.cell_list:\n            if cell.type == self.cell_type_neoplastic:\n                cell.targetVolume = 25\n                cell.lambdaVolume = 2.0\n            elif cell.type == self.cell_type_endothelial:\n                cell.targetVolume = 15\n                cell.lambdaVolume = 3.0\n        \n        self.initialize_field(\"VEGF\", 0.0)\n        \n    def step(self, mcs):\n        vegf_field = self.getConcentrationField('VEGF')\n        \n        for cell in self.cell_list_by_type(self.cell_type_neoplastic):\n            if self.oxygen_level(cell) < self.hypoxia_threshold:\n                self.secrete_substance(cell, vegf_field, self.vegf_secretion_rate)\n                \n            if random.random() < self.proliferation_prob:\n                self.divide_cell_random_orientation(cell)\n        \n        for cell in self.cell_list_by_type(self.cell_type_endothelial):\n            if mcs % 10 == 0 and cell.volume > 30:\n                self.divide_cell_along_vector(cell, 1, 0, 0)\n\n    def oxygen_level(self, cell):\n        return self.getConcentration('Oxygen', cell.xCOM, cell.yCOM, cell.zCOM)\n\n    def secrete_substance(self, cell, field, rate):\n        field[cell.xCOM, cell.yCOM, cell.zCOM] += rate\n\nCompuCellSetup.register_steppable(steppable=AngiogenesisSteppable(sim, 1))\nCompuCellSetup.run()\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D Python script.\n\nFirst, the necessary imports: CompuCellSetup and the steppables module. Then, a simulation class that inherits from SteppableBasePy. The class must have __init__, start, and step methods.\n\nThe ontology annotations mention two cell types: endothelial and neoplastic cells. So I'll define those in the start method using self.cellType. The GeneOntology terms include response to hypoxia, chemotaxis, blood vessel development, cell proliferation, and angiogenesis. MeSH terms relate to neoplasm angiogenesis, hypoxia, cell proliferation, pathologic neovascularization, and chemotaxis.\n\nI should incorporate parameters that reflect these processes. For hypoxia response, maybe set a hypoxia threshold and a VEGF secretion rate. Chemotaxis can be handled by adding a chemical field (like VEGF) and setting up chemotaxis parameters for endothelial cells towards VEGF. Cell proliferation can be controlled by a probability parameter, adjusting the growth rate.\n\nIn the __init__ method, I'll initialize the basic simulation parameters. The start method will define cell types and set up the initial cells. Maybe place some neoplastic cells and endothelial cells initially. Also, set up the VEGF field and configure chemotaxis here.\n\nIn the step method, during each Monte Carlo Step (MCS), I'll check conditions for hypoxia. If a cell is neoplastic and the local VEGF concentration is above the threshold, maybe increase proliferation probability. For endothelial cells, maybe check if they should undergo chemotaxis or angiogenesis. Also, handle cell division based on the proliferation probability.\n\nI need to make sure to register the steppable with CompuCellSetup at the end. Also, include the standard run line. Remember to use the right syntax for adding steppables and initializing the simulation.\n\nWait, for the VEGF field, I should declare it as a ChemicalField in the simulation. Then in the start method, set up chemotaxis by using the FlexibleDiffusionSolverFE and adding the chemical field to it. Also, configure the diffusion parameters and decay rate if needed.\n\nFor cell division, maybe use the divideCell function. But in the step method, loop through all cells and apply the proliferation probability. When a cell is to divide, split it. Also, for hypoxia response, maybe have neoplastic cells secrete VEGF when they're under hypoxic conditions.\n\nI think that's the basic structure. Let me put it all together, making sure all required methods are present and parameters are based on the ontology terms provided.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nfrom pyevtk.hl import *\nfrom math import *\nimport random\nimport CompuCellSetup\nfrom CompuCellSetup import sim\nimport sys\nfrom PySteppables import *\n\nclass AngiogenesisSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        SteppableBasePy.__init__(self, _simulator, _frequency)\n        self.hypoxia_threshold = 0.2\n        self.proliferation_prob = 0.01\n        self.vegf_secretion_rate = 0.1\n        self.chemotaxis_strength = 10.0\n\n    def start(self):\n        self.cell_type_endothelial = self.cellType(\"ENDOTHELIAL\")\n        self.cell_type_neoplastic = self.cellType(\"NEOPLASTIC\")\n        \n        self.vessel_field = self.createChemotaxisField('VEGF')\n        self.addChemotaxisData(self.cell_type_endothelial, 'VEGF', self.chemotaxis_strength)\n        \n        for cell in self.cell_list:\n            if cell.type == self.cell_type_neoplastic:\n                cell.targetVolume = 25\n                cell.lambdaVolume = 2.0\n            elif cell.type == self.cell_type_endothelial:\n                cell.targetVolume = 15\n                cell.lambdaVolume = 3.0\n        \n        self.initialize_field(\"VEGF\", 0.0)\n        \n    def step(self, mcs):\n        vegf_field = self.getConcentrationField('VEGF')\n        \n        for cell in self.cell_list_by_type(self.cell_type_neoplastic):\n            if self.oxygen_level(cell) < self.hypoxia_threshold:\n                self.secrete_substance(cell, vegf_field, self.vegf_secretion_rate)\n                \n            if random.random() < self.proliferation_prob:\n                self.divide_cell_random_orientation(cell)\n        \n        for cell in self.cell_list_by_type(self.cell_type_endothelial):\n            if mcs % 10 == 0 and cell.volume > 30:\n                self.divide_cell_along_vector(cell, 1, 0, 0)\n\n    def oxygen_level(self, cell):\n        return self.getConcentration('Oxygen', cell.xCOM, cell.yCOM, cell.zCOM)\n\n    def secrete_substance(self, cell, field, rate):\n        field[cell.xCOM, cell.yCOM, cell.zCOM] += rate\n\nCompuCellSetup.register_steppable(steppable=AngiogenesisSteppable(sim, 1))\nCompuCellSetup.run()",
      "output_file": "experiments\\batch_reasoning_20250624_020624\\paper_18_3D_Multi-Cell_20250624_020624\\run_9\\generated_cc3d_model.cc3d"
    }
  }
}